BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28679388)

  • 1. ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T.
    Menotta M; Biagiotti S; Spapperi C; Orazi S; Rossi L; Chessa L; Leuzzi V; D'Agnano D; Soresina A; Micheli R; Magnani M
    Orphanet J Rare Dis; 2017 Jul; 12(1):126. PubMed ID: 28679388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro dexamethasone treatment does not induce alternative ATM transcripts in cells from Ataxia-Telangiectasia patients.
    Pozzi E; Giorgio E; Mancini C; Lo Buono N; Augeri S; Ferrero M; Di Gregorio E; Riberi E; Vinciguerra M; Nanetti L; Bianchi FT; Sassi MP; Costanzo V; Mariotti C; Funaro A; Cavalieri S; Brusco A
    Sci Rep; 2020 Nov; 10(1):20182. PubMed ID: 33214630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity.
    Menotta M; Biagiotti S; Bianchi M; Chessa L; Magnani M
    J Biol Chem; 2012 Nov; 287(49):41352-63. PubMed ID: 23055520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia.
    Menotta M; Biagiotti S; Orazi S; Rossi L; Chessa L; Leuzzi V; D'Agnano D; Plebani A; Soresina A; Magnani M
    Mol Cell Biochem; 2018 Jan; 438(1-2):153-166. PubMed ID: 28744812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease.
    Ricci A; Biancucci F; Morganti G; Magnani M; Menotta M
    Cell Mol Life Sci; 2022 Nov; 79(12):601. PubMed ID: 36422718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response.
    Biagiotti S; Menotta M; Orazi S; Spapperi C; Brundu S; Fraternale A; Bianchi M; Rossi L; Chessa L; Magnani M
    FEBS J; 2016 Nov; 283(21):3962-3978. PubMed ID: 27636396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells.
    Biagiotti S; Menotta M; Giacomini E; Radici L; Bianchi M; Bozzao C; Chessa L; Magnani M
    Mol Cell Biochem; 2014 Jul; 392(1-2):13-30. PubMed ID: 24627244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone.
    Menotta M; Orazi S; Gioacchini AM; Spapperi C; Ricci A; Chessa L; Magnani M
    PLoS One; 2018; 13(4):e0195388. PubMed ID: 29608596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional classification of ATM variants in ataxia-telangiectasia patients.
    Fiévet A; Bellanger D; Rieunier G; Dubois d'Enghien C; Sophie J; Calvas P; Carriere JP; Anheim M; Castrioto A; Flabeau O; Degos B; Ewenczyk C; Mahlaoui N; Touzot F; Suarez F; Hully M; Roubertie A; Aladjidi N; Tison F; Antoine-Poirel H; Dahan K; Doummar D; Nougues MC; Ioos C; Rougeot C; Masurel A; Bourjault C; Ginglinger E; Prieur F; Siri A; Bordigoni P; Nguyen K; Philippe N; Bellesme C; Demeocq F; Altuzarra C; Mathieu-Dramard M; Couderc F; Dörk T; Auger N; Parfait B; Abidallah K; Moncoutier V; Collet A; Stoppa-Lyonnet D; Stern MH
    Hum Mutat; 2019 Oct; 40(10):1713-1730. PubMed ID: 31050087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial.
    Chessa L; Leuzzi V; Plebani A; Soresina A; Micheli R; D'Agnano D; Venturi T; Molinaro A; Fazzi E; Marini M; Ferremi Leali P; Quinti I; Cavaliere FM; Girelli G; Pietrogrande MC; Finocchi A; Tabolli S; Abeni D; Magnani M
    Orphanet J Rare Dis; 2014 Jan; 9():5. PubMed ID: 24405665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).
    Asadollahi R; Britschgi C; Joset P; Oneda B; Schindler D; Meier UR; Rauch A
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1409. PubMed ID: 32748564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telangiectasias in Ataxia Telangiectasia: Clinical significance, role of ATM deficiency and potential pathophysiological mechanisms.
    Schoenaker MHD; Van Os NJH; Van der Flier M; Van Deuren M; Seyger MM; Taylor AMR; Weemaes CMR; Willemsen MAAP
    Eur J Med Genet; 2018 May; 61(5):284-287. PubMed ID: 29288088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very mild presentation in adult with classical cellular phenotype of ataxia telangiectasia.
    Worth PF; Srinivasan V; Smith A; Last JI; Wootton LL; Biggs PM; Davies NP; Carney EF; Byrd PJ; Taylor AM
    Mov Disord; 2013 Apr; 28(4):524-8. PubMed ID: 23143971
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Karamat U; Ejaz S; Hameed Y
    Genet Test Mol Biomarkers; 2021 Apr; 25(4):263-275. PubMed ID: 33877897
    [No Abstract]   [Full Text] [Related]  

  • 15. DDIT4 gene expression is switched on by a new HDAC4 function in ataxia telangiectasia.
    Ricci A; Galluzzi L; Magnani M; Menotta M
    FASEB J; 2020 Jan; 34(1):1802-1818. PubMed ID: 31914654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in splicing factor expression are associated with advancing age in man.
    Holly AC; Melzer D; Pilling LC; Fellows AC; Tanaka T; Ferrucci L; Harries LW
    Mech Ageing Dev; 2013 Sep; 134(9):356-66. PubMed ID: 23747814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ATM mutations with ataxia-telangiectasia.
    Liu XL; Wang T; Huang XJ; Zhou HY; Luan XH; Shen JY; Chen SD; Cao L
    Neurosci Lett; 2016 Jan; 611():112-5. PubMed ID: 26628246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic ataxia telangiectasia porcine model phenocopies the multisystemic features of the human disease.
    Beraldi R; Meyerholz DK; Savinov A; Kovács AD; Weimer JM; Dykstra JA; Geraets RD; Pearce DA
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2862-2870. PubMed ID: 28746835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study.
    Cirillo E; Del Giudice E; Micheli R; Cappellari AM; Soresina A; Dellepiane RM; Pietrogrande MC; Dell'Era L; Specchia F; Pession A; Plebani A; Pignata C
    Eur J Neurol; 2018 Jun; 25(6):833-840. PubMed ID: 29489040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mosaic forms of ataxia-telangiectasia].
    Kuranova ML; Pleskach NM; Ledashcheva TA; Mikhel'son VM; Spivak IM
    Tsitologiia; 2014; 56(8):619-29. PubMed ID: 25697008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.